These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27334087)

  • 1. [Foetal therapy for Down syndrome: a pro-active ethical reflection].
    de Wert GM; Dondorp WJ
    Ned Tijdschr Geneeskd; 2016; 160():D307. PubMed ID: 27334087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal therapy for Down syndrome: an ethical exploration.
    de Wert G; Dondorp W; Bianchi DW
    Prenat Diagn; 2017 Mar; 37(3):222-228. PubMed ID: 28004394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals.
    Kater-Kuipers A; Bunnik EM; de Beaufort ID; Galjaard RJH
    BMC Pregnancy Childbirth; 2018 Oct; 18(1):409. PubMed ID: 30340550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal screening: current practice, new developments, ethical challenges.
    de Jong A; Maya I; van Lith JM
    Bioethics; 2015 Jan; 29(1):1-8. PubMed ID: 25521968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.
    Ngan OMY; Yi H; Wong SYS; Sahota D; Ahmed S
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):285. PubMed ID: 28870159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive prenatal diagnosis for aneuploidy: toward an integral ethical assessment.
    de Jong A; Dondorp WJ; Frints SG; de Die-Smulders CE; de Wert GM
    Hum Reprod; 2011 Nov; 26(11):2915-7. PubMed ID: 21840907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical issues in the diagnosis and management of fetal disorders.
    Chadwick R; Childs R
    Best Pract Res Clin Obstet Gynaecol; 2012 Oct; 26(5):541-50. PubMed ID: 22901734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive prenatal testing.
    Harraway J
    Aust Fam Physician; 2017 Oct; 46(10):735-739. PubMed ID: 29036772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-invasive prenatal testing is a breakthrough in prenatal screening].
    Hornstrup LS; Ambye L; Sørensen S; Jørgensen FS
    Ugeskr Laeger; 2015 Jul; 177(28):. PubMed ID: 26239855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision-making for non-invasive prenatal testing for Down syndrome: Hong Kong Chinese women's preferences for individual vs relational autonomy.
    Lau JY; Yi H; Ahmed S
    Clin Genet; 2016 May; 89(5):550-6. PubMed ID: 26864268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal screening: an ethical agenda for the near future.
    de Jong A; de Wert GM
    Bioethics; 2015 Jan; 29(1):46-55. PubMed ID: 25521973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan.
    Shaw SW; Chen CP; Cheng PJ
    Taiwan J Obstet Gynecol; 2013 Dec; 52(4):470-4. PubMed ID: 24411028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Present status and future perspective of prenatal diagnosis in Japan].
    Saito N
    Fukuoka Igaku Zasshi; 2013 Oct; 104(10):326-33. PubMed ID: 24511662
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ethical aspects of prenatal screening for Down's syndrome].
    Tóth A; Szabó J
    Orv Hetil; 2000 Oct; 141(42):2293-8. PubMed ID: 11076495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new ethical landscape of prenatal testing: individualizing choice to serve autonomy and promote public health: a radical proposal.
    Munthe C
    Bioethics; 2015 Jan; 29(1):36-45. PubMed ID: 25521972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the extent of information desired by women undergoing non-invasive prenatal testing following positive prenatal Down-syndrome screening test results.
    Lo TK; Chan KY; Kan AS; So PL; Kong CW; Mak SL; Lee CN
    Int J Gynaecol Obstet; 2017 Jun; 137(3):338-339. PubMed ID: 28295291
    [No Abstract]   [Full Text] [Related]  

  • 18. Ethical concerns and future directions in maternal screening for Down syndrome.
    Elkins TE; Brown D
    Womens Health Issues; 1995; 5(1):15-20. PubMed ID: 7742644
    [No Abstract]   [Full Text] [Related]  

  • 19. NIPTRIC: an online tool for clinical interpretation of non-invasive prenatal testing (NIPT) results.
    Sikkema-Raddatz B; Johansson LF; de Boer EN; Boon EM; Suijkerbuijk RF; Bouman K; Bilardo CM; Swertz MA; Dijkstra M; van Langen IM; Sinke RJ; Te Meerman GJ
    Sci Rep; 2016 Dec; 6():38359. PubMed ID: 27917919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mothers of a child with Down syndrome: A qualitative analysis of the perspectives on non-invasive prenatal testing.
    Valentin C; Smidt A; Barton R; Wilson NJ; How B
    Midwifery; 2019 Sep; 76():118-124. PubMed ID: 31202107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.